Waters Corporation Share Price

Equities

WAT

US9418481035

Advanced Medical Equipment & Technology

Market Closed - Nyse 21:00:01 13/05/2024 BST 5-day change 1st Jan Change
349.3 USD -0.52% Intraday chart for Waters Corporation +9.20% +6.09%
Sales 2024 * 2.97B 237B Sales 2025 * 3.15B 251B Capitalization 20.72B 1,652B
Net income 2024 * 637M 50.8B Net income 2025 * 719M 57.34B EV / Sales 2024 * 7.43 x
Net Debt 2024 * 1.31B 105B Net Debt 2025 * 1.1B 87.54B EV / Sales 2025 * 6.93 x
P/E ratio 2024 *
32.3 x
P/E ratio 2025 *
28.4 x
Employees 7,900
Yield 2024 *
-
Yield 2025 *
-
Free-Float 36.4%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.52%
1 week+9.20%
Current month+13.02%
1 month+8.25%
3 months+12.10%
6 months+39.17%
Current year+6.09%
More quotes
1 week
323.34
Extreme 323.34
352.56
1 month
288.94
Extreme 288.94
352.56
Current year
288.94
Extreme 288.94
363.80
1 year
231.90
Extreme 231.9
363.80
3 years
231.90
Extreme 231.9
428.22
5 years
154.39
Extreme 154.39
428.22
10 years
93.56
Extreme 93.56
428.22
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 31/08/20
Director of Finance/CFO 48 11/05/21
Chief Operating Officer - 31/12/21
Members of the board TitleAgeSince
Director/Board Member 65 31/08/18
Director/Board Member 68 26/03/23
Director/Board Member 70 30/04/06
More insiders
Date Price Change Volume
13/05/24 349.3 -0.52% 437,115
10/05/24 351.1 +4.37% 791,251
09/05/24 336.4 +3.90% 431,018
08/05/24 323.8 -0.69% 399,532
07/05/24 326.1 +1.94% 997,389

Delayed Quote Nyse, May 13, 2024 at 09:00 pm

More quotes
Waters Corporation specializes in the conception, the manufacturing and the marketing of analytical instruments. Net sales break down by activity as follows: - sale of instruments and analytical systems (63.6%): chromatographic analysis instruments (59.5% of net sales; instruments high performance liquid chromatography and mass spectrometry), chemistry consumables (28.9%; including columns chemical separation) and thermal analysis, rheometry and calorimetry instruments (11.6%) ; - services (36.7%): support services, training, etc. Net sales are distributed by market between pharmaceutical (58.6%), industrial (29.9%), academic institutions and governmental agencies (11.4%). Net sales are distributed geographically as follows: the United States (28.7%), Americas (5.1%), China (17.1%), Japan (7.6%), Asia (13.3%) and Europe (28.2%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
349.3 USD
Average target price
324.4 USD
Spread / Average Target
-7.13%
Consensus